Authors

• Judith D. Goldberg (ORCID: https://orcid.org/0000-0003-3758-6976)
• Paul E. Oberstein (ORCID: https://orcid.org/0000-0001-5918-6004)
• Tsivia Hochman
• Aaron J. Scott (ORCID: https://orcid.org/0000-0002-0301-3072)
• Colin D. Weekes (ORCID: https://orcid.org/0000-0001-6287-4334)
• Elliot Newman (ORCID: https://orcid.org/0000-0002-7932-2891)
• Raed Moh’d Taiseer Al-Rajabi (ORCID: https://orcid.org/0000-0003-1432-2337)
• Deirdre Jill Cohen (ORCID: https://orcid.org/0000-0002-6178-9266)
• Alec J. Megibow (ORCID: https://orcid.org/0000-0002-3126-3407)
• Tanios Bekaii‐Saab (ORCID: https://orcid.org/0000-0001-7721-1699)
• Wells A. Messersmith (ORCID: https://orcid.org/0000-0003-2349-0885)
• Lawrence Leichman
• Kevin Du

Institutions

• Lenox Hill Hospital (US)
• The Medical Center of Aurora (US)
• Yale University (US)
• NYU Langone Health (US)
• Center for Neuro-Oncology (US)
• Mayo Clinic in Arizona (US)
• Tisch Hospital (US)
• Mayo Clinic Hospital (US)
• University of Kansas Medical Center (US)
• Center for Cancer Research (US)
• Arizona Oncology (US)
• New York University (US)
• University of Colorado Denver (US)
• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

The Oncologist

Published

2025-09-16

DOI

https://doi.org/10.1093/oncolo/oyaf271

Primary Topic

Pancreatic and Hepatic Oncology Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Celgene
• NYU Grossman School of Medicine
• National Cancer Institute